We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EQH:NYSEEquitable Holdings, Inc. Analysis

Data as of 2026-05-19 - not real-time

$42.78

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Equitable Holdings (EQH) trades around $42.8, comfortably above its 20‑day SMA ($42.0) and 50‑day SMA ($39.8) but still below the 200‑day SMA ($46.1), indicating a short‑term bullish bias within a longer‑term neutral backdrop. The stock shows a modest upside of roughly 35% versus the DCF‑derived fair value of $50.5, while the forward P/E of 4.86 suggests earnings are expected to improve sharply from the current trailing loss. Technical signals are mixed: RSI sits at 57 (neutral), MACD histogram is negative and flagged bearish, and the price is testing a support zone near $39.6 with resistance around $44.8. Volume is on the rise, and the market sentiment index reads “Extreme Greed,” reflecting strong investor appetite. Fundamentally, the company carries a heavy debt load (debt‑to‑equity >300) and a negative book value per share, yet it maintains a 2.5% dividend yield supported by ample cash reserves. Recent earnings beats and upward‑adjusted analyst targets (median $58) add momentum, but the high volatility (≈37% 30‑day) and sizable beta (≈1.4) underscore considerable risk.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near technical support with upside to $44.8 resistance
  • Recent earnings beat and upward analyst target revisions
  • Increasing volume indicating buying interest

Medium Term

1–3 years
Neutral
Model confidence: 8/10

Key Factors

  • Forward earnings outlook improving (forward P/E 4.86)
  • High debt and negative free cash flow constrain upside
  • Dividend yield provides income while fundamentals remain fragile

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair value suggests ~35% upside over current price
  • Strong analyst consensus (median target $58, strong‑buy)
  • Diversified financial services platform offers growth avenues despite current volatility

Key Metrics & Analysis

Financial Health

Revenue Growth-7.60%
Profit Margin-7.26%
P/E Ratio4.9
ROE-13.52%
ROA-0.05%
Debt/Equity321.16
P/B Ratio-15.1
Op. Cash Flow$1.1B
Free Cash Flow$-9287000064
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI57.4
Support$39.58
Resistance$44.78
MA 20$41.99
MA 50$39.83
MA 200$46.11
MACDBearish
VolumeIncreasing
Fear & Greed Index89.23

Valuation

Fair Value$50.46
Target Price$57.92
Upside/Downside35.40%
GradeUndervalued
TypeBlend
Dividend Yield2.52%

Risk Assessment

Beta1.39
Volatility36.98%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.